NCT06787196View on ClinicalTrials.gov

Intravenous Dexamethasone on Postoperative Pain and Complications in Jaw Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Tooth Extraction Status NosCysts DentalGeneral Anesthesia
Interventions
DRUG

Dexamethasone

Dexamethasone, single-dose, 8 mg IV administered intraoperatively

Trial Locations (1)

42000

Funda Arun, Selçuklu

All Listed Sponsors
lead

Selcuk University

OTHER

NCT06787196 - Intravenous Dexamethasone on Postoperative Pain and Complications in Jaw Surgery | Biotech Hunter | Biotech Hunter